Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

Clinical trial NCT01922154 · COMPLETED

Trial details

NCT number: NCT01922154
Sponsor: Siriraj Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Glaucoma, Neovascular

Start date: 2009-02-01
Primary completion: 2012-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.